Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Hyperdiploid B-lymphoblastic leukemia/lymphoma with hypereosinophilia and very few circulating lymphoblasts.

Matnani R, Weissmann D.

Blood. 2020 Mar 19;135(12):974. doi: 10.1182/blood.2019004647. No abstract available.

PMID:
32191803
2.

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier.

Marcos-Contreras OA, Greineder CF, Kiseleva RY, Parhiz H, Walsh LR, Zuluaga-Ramirez V, Myerson JW, Hood ED, Villa CH, Tombacz I, Pardi N, Seliga A, Mui BL, Tam YK, Glassman PM, Shuvaev VV, Nong J, Brenner JS, Khoshnejad M, Madden T, Weissmann D, Persidsky Y, Muzykantov VR.

Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3405-3414. doi: 10.1073/pnas.1912012117. Epub 2020 Jan 31.

PMID:
32005712
3.

Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma Sharing the PCM1-JAK2 Fusion and a Common T-Cell Clone.

Riedlinger GM, Chojecki A, Aviv H, Weissmann D, Joshi S, Murphy SM, Hirshfield KM, Ganesan S.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00082. Epub 2019 Jun 19. No abstract available.

PMID:
31598574
4.

RNA editing blood biomarkers for predicting mood alterations in HCV patients.

Salvetat N, Van der Laan S, Vire B, Chimienti F, Cleophax S, Bronowicki JP, Doffoel M, Bourlière M, Schwan R, Lang JP, Pujol JF, Weissmann D.

J Neurovirol. 2019 Dec;25(6):825-836. doi: 10.1007/s13365-019-00772-9. Epub 2019 Jul 22.

5.

Correction: Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents.

Chimienti F, Cavarec L, Vincent L, Salvetat N, Arango V, Underwood MD, Mann JJ, Pujol JF, Weissmann D.

Transl Psychiatry. 2019 Mar 14;9(1):112. doi: 10.1038/s41398-019-0453-2.

6.

Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents.

Chimienti F, Cavarec L, Vincent L, Salvetat N, Arango V, Underwood MD, Mann JJ, Pujol JF, Weissmann D.

Transl Psychiatry. 2019 Feb 15;9(1):91. doi: 10.1038/s41398-018-0331-3. Erratum in: Transl Psychiatry. 2019 Mar 14;9(1):112.

7.

Emerging RNA editing biomarkers will foster drug development.

van der Laan S, Salvetat N, Weissmann D, Molina F.

Drug Discov Today. 2017 Jul;22(7):1056-1063. doi: 10.1016/j.drudis.2017.01.017. Epub 2017 Feb 7. Review.

PMID:
28188894
8.

Charcot-Leyden crystals in T-cell lymphoblastic lymphoma.

Ali ND, Weissmann D.

Blood. 2017 Jan 19;129(3):394. doi: 10.1182/blood-2016-10-743179. No abstract available.

PMID:
28104676
9.

Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression.

Weissmann D, van der Laan S, Underwood MD, Salvetat N, Cavarec L, Vincent L, Molina F, Mann JJ, Arango V, Pujol JF.

Transl Psychiatry. 2016 Aug 30;6(8):e878. doi: 10.1038/tp.2016.121.

10.

Accurate quantum chemical modelling of the separation of Eu(3+) from Am(3+)/Cm(3+) by liquid-liquid extraction with Cyanex272.

Cao X, Zhang J, Weissmann D, Dolg M, Chen X.

Phys Chem Chem Phys. 2015 Aug 28;17(32):20605-16. doi: 10.1039/c5cp03100a. Epub 2015 Jul 23.

PMID:
26203895
11.

Next generation sequencing as an aid to diagnosis and treatment of an unusual pediatric brain cancer.

Glod J, Song M, Sharma A, Tyagi R, Rhodes RH, Weissmann DJ, Roychowdhury S, Khan A, Kane MP, Hirshfield K, Ganesan S, DiPaola RS, Rodriguez-Rodriguez L.

J Pers Med. 2014 Jul 15;4(3):402-11. doi: 10.3390/jpm4030402.

12.

In vitro screening for drug-induced depression and/or suicidal adverse effects: a new toxicogenomic assay based on CE-SSCP analysis of HTR2C mRNA editing in SH-SY5Y cells.

Cavarec L, Vincent L, Le Borgne C, Plusquellec C, Ollivier N, Normandie-Levi P, Allemand F, Salvetat N, Mathieu-Dupas E, Molina F, Weissmann D, Pujol JF.

Neurotox Res. 2013 Jan;23(1):49-62. doi: 10.1007/s12640-012-9324-9. Epub 2012 Apr 13.

PMID:
22528247
13.

Aggressive behavior during social interaction in mice is controlled by the modulation of tyrosine hydroxylase expression in the prefrontal cortex.

Cambon K, Dos-Santos Coura R, Groc L, Carbon A, Weissmann D, Changeux JP, Pujol JF, Granon S.

Neuroscience. 2010 Dec 15;171(3):840-51. doi: 10.1016/j.neuroscience.2010.09.015. Epub 2010 Oct 20.

PMID:
20923695
14.

Combined computational and experimental study of uranyl(VI) 1:2 complexation by aromatic acids.

Wiebke J, Weigand A, Weissmann D, Glorius M, Moll H, Bernhard G, Dolg M.

Inorg Chem. 2010 Jul 19;49(14):6428-35. doi: 10.1021/ic902496u.

PMID:
20550140
15.

Courier qualifications.

Arnold K, Weissmann D.

MLO Med Lab Obs. 2010 Apr;42(4):56. No abstract available.

PMID:
20446474
16.

Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.

Fan G, Simmons MJ, Ge S, Dutta-Simmons J, Kucharczak J, Ron Y, Weissmann D, Chen CC, Mukherjee C, White E, Gélinas C.

Blood. 2010 Apr 29;115(17):3559-69. doi: 10.1182/blood-2009-08-236760. Epub 2010 Feb 25.

17.

Indolent T-lymphoblastic proliferation in Castleman lymphadenopathy.

Qian YW, Weissmann D, Goodell L, August D, Strair R.

Leuk Lymphoma. 2009 Feb;50(2):306-8. doi: 10.1080/10428190802645079. No abstract available.

PMID:
19197736
18.

A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.

Sriganeshan V, Blom TR, Weissmann DJ.

Arch Pathol Lab Med. 2008 Aug;132(8):1346-9. doi: 10.1043/1543-2165(2008)132[1346:AUCOMC]2.0.CO;2. Review.

PMID:
18684040
19.

Logical analysis of diffuse large B-cell lymphomas.

Alexe G, Alexe S, Axelrod DE, Hammer PL, Weissmann D.

Artif Intell Med. 2005 Jul;34(3):235-67.

PMID:
16023562
20.

From microarray to bedside: targeting NF-kappaB for therapy of lymphomas.

Rabson AB, Weissmann D.

Clin Cancer Res. 2005 Jan 1;11(1):2-6. Review. No abstract available.

Supplemental Content

Loading ...
Support Center